Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Developer of a portable, point-of-care hemodynamic measurement system that uses proprietary sensor tech and machine learning to guide care.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
SeaStar Medical is a commercial-stage medical device company that develops immunomodulating technologies.
Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.
Generating digital biomarkers for women's heart health with patented textile sensor technology
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Actuated Medical is engaged in outsourced research and development, designing, modeling, prototyping, and manufacturing medical devices.
Safi Biosolutions is biotechnology based company.
Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
Rhealth is a biotechnology company that provides health management solutions based on advanced AI through a platform to hospitals.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
Asymmetrex is a life sciences biotechnology company that develops stem cell medicine technology.
Life sciences R&D, consulting and investment
Lazzaro Medical is to assist the millions of patients who have tracheobronchomalacia (TBM).
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.
Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
WynnVision is a technology based company.
VoluMetrix is dedicated to developing breakthrough monitoring technologies to enhance people's well-being.
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection.
Vivasc Therapeutics is a drug development company that specializes in proprietary cardiac targeting peptide platform technology.
National Heart has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Heart's top investment sectors include Biotechnology, Health Care, Medical Device, Medical, Pharmaceutical. The firm invests across 26 different industry categories.
Among tracked funding rounds, Perosphere Technologies received $7.5M in a Venture - Series Unknown round. National Heart's total known invested capital is $235.7M.
National Heart's average investment size is $4.1M across its portfolio of 55 companies.
Recent National Heart portfolio additions include Xylyx Bio, Sensydia, Sinopia Biosciences, RICOVR Healthcare, SeaStar Medical. These companies were founded in 2020 or later.